You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 11, March 16, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Prospect of Silencing Disease Using RNA Interference

Premlata Shankar, MD; N. Manjunath, MD; Judy Lieberman, MD, PhD

JAMA. 2005;293:1367-1373.

The discovery of RNA interference (RNAi), an endogenous cellular gene-silencing mechanism, has already provided a powerful tool for basic science researchers to study gene function. The subsequent finding that RNAi also operates in mammalian cells has generated excitement regarding potential therapeutic applications. In this article we discuss the basic mechanism of RNAi and the therapeutic opportunities and obstacles for harnessing RNAi for therapy of human disease.


Author Affiliations: CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Importance of Biodiversity to Medicine
Bernstein and Ludwig
JAMA 2008;300:2297-2299.
FULL TEXT  

Intraperitoneal Injection of a Hairpin RNA Expressing Plasmid Targeting Urokinase-Type Plasminogen Activator (uPA) Receptor and uPA Retards Angiogenesis and Inhibits Intracranial Tumor Growth in Nude Mice
Gondi et al.
Clin. Cancer Res. 2007;13:4051-4060.
ABSTRACT | FULL TEXT  

Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions
Valiunas et al.
J. Physiol. 2005;568:459-468.
ABSTRACT | FULL TEXT  

US Biomedical Research: Basic, Translational, and Clinical Sciences
Zerhouni
JAMA 2005;294:1352-1358.
ABSTRACT | FULL TEXT  

Gene Therapy Yields to RNA Interference
Fisher Wilson
ANN INTERN MED 2005;143:161-164.
FULL TEXT  

In vivo RNA Interference-Mediated Ablation of MDR1 P-Glycoprotein
Pichler et al.
Clin. Cancer Res. 2005;11:4487-4494.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.